Viewing StudyNCT00160992



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00160992
Status: SUSPENDED
Last Update Posted: 2005-09-12
First Post: 2005-09-08

Brief Title: Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients
Sponsor: University of Lausanne Hospitals
Organization: University of Lausanne Hospitals

Organization Data

Organization: University of Lausanne Hospitals
Class: OTHER
Study ID: CePO-ITA-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Lausanne Hospitals
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
NCCR National Center of Competence in Resaerch Switzerland NETWORK
Fondaction contre le cancer UNKNOWN
Barletta Foundation OTHER